1. Home
  2. CMCO vs AUPH Comparison

CMCO vs AUPH Comparison

Compare CMCO & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCO
  • AUPH
  • Stock Information
  • Founded
  • CMCO 1875
  • AUPH 1993
  • Country
  • CMCO United States
  • AUPH Canada
  • Employees
  • CMCO N/A
  • AUPH N/A
  • Industry
  • CMCO Construction/Ag Equipment/Trucks
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCO Industrials
  • AUPH Health Care
  • Exchange
  • CMCO Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • CMCO 936.9M
  • AUPH 1.0B
  • IPO Year
  • CMCO 1996
  • AUPH 1999
  • Fundamental
  • Price
  • CMCO $33.63
  • AUPH $7.32
  • Analyst Decision
  • CMCO Strong Buy
  • AUPH Strong Buy
  • Analyst Count
  • CMCO 2
  • AUPH 3
  • Target Price
  • CMCO $51.50
  • AUPH $10.33
  • AVG Volume (30 Days)
  • CMCO 216.7K
  • AUPH 825.6K
  • Earning Date
  • CMCO 10-30-2024
  • AUPH 11-07-2024
  • Dividend Yield
  • CMCO 0.83%
  • AUPH N/A
  • EPS Growth
  • CMCO N/A
  • AUPH N/A
  • EPS
  • CMCO 0.52
  • AUPH N/A
  • Revenue
  • CMCO $1,001,648,000.00
  • AUPH $207,105,000.00
  • Revenue This Year
  • CMCO $3.70
  • AUPH $36.08
  • Revenue Next Year
  • CMCO $3.90
  • AUPH $19.41
  • P/E Ratio
  • CMCO $64.17
  • AUPH N/A
  • Revenue Growth
  • CMCO 2.41
  • AUPH 29.35
  • 52 Week Low
  • CMCO $29.26
  • AUPH $4.71
  • 52 Week High
  • CMCO $45.84
  • AUPH $10.05
  • Technical
  • Relative Strength Index (RSI)
  • CMCO 52.96
  • AUPH 56.35
  • Support Level
  • CMCO $31.37
  • AUPH $7.03
  • Resistance Level
  • CMCO $32.76
  • AUPH $7.50
  • Average True Range (ATR)
  • CMCO 1.00
  • AUPH 0.21
  • MACD
  • CMCO -0.13
  • AUPH 0.00
  • Stochastic Oscillator
  • CMCO 69.83
  • AUPH 72.31

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, Middle East, and Africa.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: